Senegal | Infectious diseases | Diagnostics innovation

At the Institut Pasteur de Dakar, the project team are developing a rapid molecular diagnostic test for measles on lateral flow strips and in cassette form, using CRISPR technology, previously used mainly in the field of genome editing. The end product will enable rapid, highly sensitive diagnosis, and could potentially offer a cheaper alternative to current diagnostic methods in the future. This will significantly boost the level of measles virus surveillance, particularly in low-resource environments. The team plans to validate the test across various healthcare settings, ensuring its accessibility and reliability, and will conduct training for healthcare professionals to facilitate prompt and accurate diagnoses.